Join us for this webinar as our panel of experts provide a thorough understanding of how clinical trial outcomes impact biopharma company valuations. Speakers Catherine Beech MB,ChB,OBE, Amir Hefni, William Harries and Joe Hopcraft will explore the underlying drivers of these impacts, such as trial results compared to investors’ prior expectations, development phase at readout, therapy area, and trial design. https://lnkd.in/gjfAsrua #biotech
IQVIA
Hospitals and Health Care
Durham, North Carolina 2,047,883 followers
Accelerate innovation for a healthier world.
About us
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
- Website
-
https://www.iqvia.com/
External link for IQVIA
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Durham, North Carolina
- Type
- Public Company
- Specialties
- Technology, Consulting, and Clinical Development
Locations
-
Primary
2400 Ellis Rd
Durham, North Carolina 27703, US
Employees at IQVIA
Updates
-
Considering a move to #IQVIA, but your dream job isn't available yet? ✍🏽 Join our Global Talent Network and we'll let you know when it is! https://bit.ly/4d4FeZd #WeAreIQVIA
-
-
Looking for industry-leading #RealWorldEvidence perspectives? Access #IQVIA's Real World Evidence Library for expert content to help you meet stakeholder needs with confidence and get real results. https://bit.ly/3XMZNEQ
-
A new white paper from the Regulatory Affairs and Drug Development Solutions' team of experts explores trends and insights on how proactive regulatory strategies, automation in publishing and labeling, and advanced analytics are revolutionizing the biopharma industry.
Are you aware of the latest regulatory trends in the biopharma industry? Our new white paper, “The Future of Regulatory Operations: Adapting to Emerging Trends in Lifecycle Management for Biopharma”, explores how the future of regulatory affairs includes flexible partnerships, AI and ML technology implementation, predictive analytics, and adapting to an evolving regulatory landscape. Learn expert insights from Marcela Miño, Rama Mohan Rao Chikkam, Keith McDonald, and David Cameron, on how proactive regulatory strategies, automation in publishing and labeling, and advanced analytics are revolutionizing the biopharma industry. Read the full white paper here: https://bit.ly/3RGNHsW #RegulatoryOperations #AI #Biopharma #RegulatoryAffairs #RegulatoryStrategy #LCM
-
-
Don’t miss our upcoming webinar! Find out how to accelerate multi-country research with global OMOP data with access to 2B+ harmonized patient records. https://bit.ly/3W4C0z8 #RWD #realworlddata #DataDelivered
-
-
President, Europe, Middle East, Africa and South Asia & Global Head of Public Health, Alistair Grenfell, takes 60 seconds to give his perspective on collaborating with life sciences customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients globally. Join IQVIA in creating a healthier world: https://bit.ly/3RSGKoP #WeAreIQVIA
-
Join IQVIA Consumer Health, Danone and Haleon to explore how the growing gap between total life expectancy and healthy life expectancy is opening new growth paths in consumer health. Register below!
Join IQVIA Consumer Health, Danone and Haleon to explore how the growing gap between total life expectancy and healthy life expectancy is opening new growth paths in consumer health: https://lnkd.in/eR8HSrzH Speakers: Sheryl Tan, Jill Wong, Aida Gadzhieva-Moore and Matt Stewart #Health #Danone #Haleon IQVIA Asia Pacific
-
-
There are no validated COAs for patients with late-onset GM2 gangliosidoses – a rare disease affecting adolescents and young adults. IQVIA’s Robert Krupnick co-authored this research on the available COAs that could properly measure disease impact, burden, and progression. Read how the team was able to identify the utility of existing measures. https://bit.ly/4eZikUT
-
-
Antibody levels can help inform future #COVID19 infection risk and optimize booster scheduling. This article by IQVIA’s Caroline Tai, Miriam Haviland, Christina Mack, Rachel McFarland Lucia, Ph.D. and industry colleagues explores how an integrated evidence hub of health, lab, and genomic sequencing data from the NBA was used to evaluate the relationship between antibody levels and risk of #COVID19 infection – contributing to an understanding of real world effectiveness and global public health. https://bit.ly/3zy6q3I
-
-
Strategically designed and timed #naturalhistorystudies can lead to more efficient and effective use of data to address key evidence gaps. Learn how these methods have helped sponsors mitigate risks and enhance interactions with health authorities, driving success in regulatory submissions.
Join us to learn how #naturalhistorystudies can be the key that unlocks a deeper understanding of disease progression and patient outcomes, leading to successful regulatory submissions. We will share real-world case studies highlighting the impact of applying a natural history study to your approach to #clinicaldevelopment. Register now and be part of this pivotal discussion! https://bit.ly/3RKFFPO #Webinar #RegulatoryAffairs #EvidenceBasedDecisionMaking
Affiliated pages
Similar pages
Browse jobs
Stock
IQV
NYSE
20 minutes delay
$208.10
1.29 (0.624%)
- Open
- 207.42
- Low
- 205.06
- High
- 208.5
Data from Refinitiv
See more info on